District Mapping Onchocerciasis, Lymphatic Filariasis, and Loiasis in Gabon
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'The purpose of the study was to define a cost-effective and accurate method to map ivermectin-naïve districts for Onchocerciasis, Lymphatic Filariasis and Loiasis and identify districts eligible for safe treatment with ivermectin MDA. The study aimed primarily to validate a statistical model calibrated to determine whether community-level prevalence of Loa infection of >20,000 mf/mL is less than 1% in a community by comparing results of the model to results of a community-level random sample prevalence assessment' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Loa loa antibody rapid test","LoaScope","Loiasis","Lymphatic Filariasis","Onchocerciasis","Oncho/LF IgG4 biplex RDT"]} <|eot_id|>
 Here is the Description of a dataset. Description:'The purpose of the study was to define a cost-effective and accurate method to map ivermectin-naïve districts for Onchocerciasis, Lymphatic Filariasis and Loiasis and identify districts eligible for safe treatment with ivermectin MDA. The study aimed primarily to validate a statistical model calibrated to determine whether community-level prevalence of Loa infection of >20,000 mf/mL is less than 1% in a community by comparing results of the model to results of a community-level random sample prevalence assessment' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
The purpose of the study was to define a cost-effective and accurate method to map ivermectin-naïve districts for Onchocerciasis, Lymphatic Filariasis and Loiasis and identify districts eligible for safe treatment with ivermectin MDA. The study aimed primarily to validate a statistical model calibrated to determine whether community-level prevalence of Loa infection of >20,000 mf/mL is less than 1% in a community by comparing results of the model to results of a community-level random sample prevalence assessment
Loa loa antibody rapid test; LoaScope; Loiasis; Lymphatic Filariasis; Onchocerciasis; Oncho/LF IgG4 biplex RDT